For the Inventor, By the Inventor

Enter assignee name

Columbia, MD, United States of America

New Horizons Diagnostics Corporation

Calculating rank

USPTO Granted Patents = 29

% Expired Patents = 31.0

CIPO Patents = 1

Forward Citations = 624

Loading Chart...

Loading Chart...

8 inventors (with patents filed for the assignee):

Lawrence J Loomis (22 out of 36 patents)

Vincent A Fischetti (21 out of 85 patents)

David T Bernstein (4 out of 16 patents)

4. C David Miller (2 out of 3 patents)

5. Vincent Fiochetti (1 out of 1 patent)

6. Lawrence Loomie (1 out of 1 patent)

7. David Trudil (1 out of 2 patents)

8. Duane A Olsen (1 out of 3 patents)

9. David Bernstein (0 patent)

Core Competencies:

Phage Associated Lytic Enzymes

Bacterial Infections

Upper Respiratory Illnesses

Dermatological Infections

Nasal Spray

Vaginal Suppository

Ocular Infections

Dental Caries

Detection Methods

Immunoassay

Solid Phase Assay

Prophylactic Treatments

29 patents: Sort by Forward Citations

1. 7232576 - [object Object] (2007-06-19),

2. 7169408 - Bandage composition containing phage associated lytic enzymes useful for treating dermatological infections (2007-01-30),

3. 7141241 - Use of bacterial phage associated lysing enzymes for treating upper respiratory illnesses (2006-11-28),

4. 7063837 - Syrup composition containing phage associated lytic enzymes (2006-06-20),

5. 7014850 - Nasal spray for treating streptococcal infections (2006-03-21),

6. 6936244 - Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract (2005-08-30),

7. 6899874 - Method for the treatment of bacterial vaginal infections (2005-05-31),

8. 6893635 - Therapeutic treatment of upper respiratory infections using a nasal spray (2005-05-17),

9. 6875431 - Method for the treatment of bacterial eye infections (2005-04-05),

10. 6432444 - Use of bacterial phage associated lysing enzymes for treating dermatological infections (2002-08-13),

11. 6428784 - Vaginal suppository for treating group B Streptococcus infection (2002-08-06),

12. 6406692 - Composition for treatment of an ocular bacterial infection (2002-06-18),

13. 6399098 - Composition for treating dental caries caused by streptococcus mutans (2002-06-04),

14. 6399097 - Composition for treatment of a bacterial infection of the digestive tract (2002-06-04),

15. 6395504 - Use of phage associated lytic enzymes for the rapid detection of bacterial contaminants (2002-05-28),

Company Overview

New Horizons Diagnostics Corporation, based in Columbia, MD, specializes in the development and manufacturing of innovative diagnostic solutions. The company focuses on advancing medical technologies that enhance disease detection and management, particularly in the fields of molecular diagnostics and laboratory testing. By leveraging cutting-edge research, New Horizons aims to improve patient outcomes through accurate and timely diagnostics, contributing to the broader healthcare landscape with its commitment to quality and innovation.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

29 Patents

#16 in Columbia, MD

#146 in Maryland

#11,640 in US

#22,595 in the World

Columbia, MD, United States of America

New Horizons Diagnostics Corporation

Forward Citations = 624

8 inventors:

Lawrence J Loomis (22 out of 36 patents)

Vincent A Fischetti (21 out of 85 patents)

David T Bernstein (4 out of 16 patents)

4. C David Miller (2 out of 3 patents)

5. Vincent Fiochetti (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: New Horizons Diagnostics Corporation. Retrieved from https://idiyas.com/company/new-horizons-diagnostics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…